GLP-1 Drugs Drive Growth for Eli Lilly. Is the Stock a Buy?
Eli Lilly continues to see strong growth coming from its GLP-1 drugs. The company's current 2025 guidance looks conservative.
BioPharma Dive1d
New study offers hints of GLP-1 drugs’ potential in curbing alcohol cravings
A small semaglutide trial suggests the medicine's suppression of appetite may extend to alcohol, but larger tests are needed ...
Food & Wine19d
GLP-1 Users Are Spending Way Less on Groceries and Fast Food, According to a New Study
Ozempic, Mounjaro, and other glucagon-like peptide-1 medications, otherwise known ... used a "difference-in-differences" framework to compare GLP-1 adopters and non-adopters and found that ...
CNN24d
Popular GLP-1 medications may have health benefits that extend beyond weight loss and blood sugar control, a new study finds
Popular GLP-1 ... compare to treatments that are already available. There’s at least one study underway to try to answer some of those questions. Other studies are also testing to see whether ...
Hosted on MSN24d
Popular GLP-1 medications may have health benefits that extend beyond weight loss and blood sugar control, a new study finds
(CNN) — Popular GLP-1 medications approved for weight loss ... as well as how they compare to treatments that are already available. There’s at least one study underway to try to answer ...